Related Experiment Video
Updated: Oct 9, 2025

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
Clinical Usefulness of Transjugular Liver Biopsy in Patients With Hematological Diseases With Liver Dysfunction
Toru Ishikawa1, Erina Kodama2, Takamasa Kobayashi2
1Department of Gastroenterology and Hepatology, Saiseikai Niigata Hospital, Niigata, JPN.
Insights
Transjugular liver biopsy (TJLB) is crucial for diagnosing liver dysfunction in patients with hematological diseases when other methods fail. This study highlights TJLB
Area of Science:
- Hepatology
- Hematology
- Interventional Radiology
Background:
- Percutaneous liver biopsy is contraindicated in patients with hematological diseases and liver dysfunction.
- Transjugular liver biopsy (TJLB) offers an alternative diagnostic method in these complex cases.
- The clinical utility of TJLB for liver disorders in hematological patients requires further investigation.
Purpose of the Study:
- To evaluate the clinical efficacy and diagnostic yield of Transjugular liver biopsy (TJLB).
- To assess the role of TJLB in guiding therapeutic strategies for liver dysfunction in hematological patients.
Main Methods:
- Retrospective analysis of 27 patients with hematological diseases and liver dysfunction requiring TJLB.
- Review of clinical features and histological diagnoses obtained via TJLB.
- Correlation of TJLB findings with subsequent treatment modifications.
Main Results:
- TJLB successfully diagnosed various liver disorders, including drug-induced liver injury, nonalcoholic steatohepatitis, autoimmune hepatitis, and liver infiltration by underlying hematological diseases.
- Specific diagnoses included drug-induced liver injury (n=8), liver infiltration (n=5), autoimmune hepatitis (n=3), nonalcoholic steatohepatitis (n=2), and others.
- Therapeutic regimens were altered based on TJLB findings, demonstrating its clinical impact.
Conclusions:
- Liver disorders in patients with hematological diseases have diverse etiologies.
- Histological diagnosis via TJLB is essential for determining appropriate treatment strategies.
- TJLB plays a vital role in managing complex liver dysfunction in hematological patients.
Abstract:
Introduction Transjugular liver biopsy (TJLB) is indicated for patients in whom percutaneous liver biopsy is contraindicated, such as those with hematological diseases complicated by liver dysfunction. However, the clinical utility of TJLB in this group of patients has not been thoroughly investigated. The objective of this study is to evaluate the clinical efficacy of TJLB in patients with hematological diseases complicated by liver dysfunction. Methods We analyzed the data of patients who developed liver disorders during treatment for hematological diseases at our hospital and required tissue diagnosis via TJLB. The clinical features of patients were analyzed. Results Twenty-seven patients (mean age, 60.07 years; 12 men, 15 women) requiring tissue diagnoses via TJLB after developing liver disorders while undergoing treatment for hematological diseases were enrolled. One patient with autoimmune hemolytic anemia was diagnosed with drug-induced liver injury; two patients with amyloidosis had nonalcoholic steatohepatitis; one patient with acute promyelocytic leukemia had a drug-induced liver injury; one patient with chronic myelomonocytic leukemia had liver infiltration caused by an underlying disease; three patients with idiopathic thrombocytopenic purpura had autoimmune hepatitis; four patients with malignant lymphoma had liver infiltration by the underlying disease, and one patient with multiple myeloma had liver disorder caused by disseminated intravascular coagulation. Moreover, one patient had hepatitis B reactivation, another had hepatitis E, and six patients had a drug-induced liver injury. The treatment regimen was altered in cases of liver infiltration caused by the underlying disease, and the drug was changed for patients with drug-induced liver injury. Conclusion The etiology of liver disorders in patients with hematological diseases varies widely. Therefore, histological diagnosis using TJLB is useful to determine an appropriate therapeutic strategy for underlying hematological diseases.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):

